Information obtained by comparing cystic fibrosis transmembrane conductance regulator sequences has been used to refine the domain structure of the protein, to better understand the effects of the many mutations identified in typical and atypical cystic fibrosis patients, and to develop better animal models for cystic fibrosis studies.
Keywords: cystic fibrosis transmembrane conductance regulator; disease model; domain structure; missense mutation; phylogeny






